Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

• Auteurs principaux: Alejandro Bimbo Diaz (Auteur), Jeremy Chow (Auteur), Fan Kee Hoo (Auteur), Kok Wei Koh (Auteur), Gary Chin Keong Lee (Auteur), Wee Siong Teo (Auteur), Narayanaswamy Venketasubramanian (Auteur), Chun-Chieh Wang (Auteur), Radhika Mehta (Auteur)
• Format: Livre
• Publié: BioExcel Publishing Ltd, 2023-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...